SlideShare a Scribd company logo
Dr. Zia Hashim
M.D. (Internal Medicine), D.M. (Pulmonary & CriticalCare), FCCP
Associate Professor
Department of Pulmonary Medicine
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow
 Tuberculosis and sarcoidosis are both
granulomatous diseases which affect
multiple systems
 Tubercular sarcoid:When both of them
coexist in the same patient
 TB bacilli are inhaled
 Engulfed by Alveolar Macrophages but cannot
digest
 Macrophages lose motility accumulate at the
site of injury. More cells are recruited (T cells)
 Small area of fibrous cuffing occurs and infection
is contained
 Disease: If there is change in immunity:
granuloma caseates and rupture
 Airway
 Blood stream
 Poorly degraded antigen
 Infectious antigens
 ? Mycobacterium tuberculosis: strong contender
 Non infectious
 Pollens
 Insecticides
 25% of sarcoidosis tissues have evidence of
mycobacterial DNA that is 15-fold greater
than in nonsarcoidosis control tissues
 Copies of mycobacteria DNA in tissue from
sarcoidosis patients are
 1000-fold less than in the tissues of patients
infected with Mycobacterium tuberculosis
CONSTITUTIONAL SYMPTOMS
 Fever
 Malaise
 Anorexia
 Weight loss
 Fatigue
RESPIRATORY SYMPTOMS
 Cough
 Dyspnea
 Chest pain
SARCOIDOSIS PATIENTS
“WALK IN”
TUBERCULOSIS PATIENTS
“BROUGHT IN”
TUBERCULOSIS
 Asymptomatic: Unlikely
 Expectoration
 Hemoptysis
 Patient is usually sick
 If constitutional symptoms
are more tuberculosis is
more likely
SARCOIDOSIS
 May remain asymptomatic
 Fatigue is characteristic
TUBERCULOSIS
 Any age
 Any sex
 Low immunity
 Low socioeconomic status
SARCOIDOSIS
 20-40 years
 F: M 2:1
 Lofgren’s syndrome
 Heerfordt’s syndrome
 Lupus pernio
 Sjogren like syndrome
 Facial nerve palsy: unilateral or bilateral
 Fever
 Parotid gland
enlargement
 Uveitis
 Xerostomia
 Facial nerve palsy:
unilateral or bilateral
 Characterized by
destructive lesions
Involvement of
 Nose
 Alae nasi
 Cheek
 Nasolabial folds
 Granulomatous uveitis
(Most common ocular
manifestation)
 Conjunctival granuloma
 Episcleritis
 Lacrimal gland
involvement (Dry eyes)
 Cervical lymphadenopathy
 Pleural and pericardial effusion
 Ascites
 Ileocaecal tuberculosis: Intestinal obstruction
 Tubercular meningitis
 Tuberculosis: Present
 Sarcoidosis: Absent
 Lacrimal and parotid: Sarcoidosis
 Adrenal gland:Tuberculosis
 Myocardial involvement, Heart block:
Sarcoidosis
POSTTB OBSTRUCTIVE DS
CHRONIC END STAGE
SARCOIDOSIS
 If positive diagnosis of tuberculosis likely
but sarcoidosis is very unlikely
 But if negative compatible clinical picture is
required to exclude tuberculosis with
confidence
CECT is required for characterization
 Sarcoidosis: Symmetrical
 Tuberculosis: Asymmetrical
 Symmetric hilar and
mediastinal
lymphadenopathy;
without or with
characterstic pulmonary
changes
 Uniform enhancement
 Discrete
 No central necrosis
 Low attenuation or typical rim
enhancement with central necrosis
 Associated lung changes/ pleural effusion
 Often asymmetrical
 Heterogeneous
BRONCHIOLE
ARTERY
VEIN & LYMPHATICS
BRONCHIOLE
ARTERY
VEIN & LYMPHATICS
CENTRILOBULAR
NODULES
PERILYMPHATIC
NODULES
 Random:
 Touch pleura
 Not related to any
structure
 Centrilobular: Away
from pleura in the centre
of lobule
 Perilymphatic:
 Touch pleura
 Along vessels, bronchi
 Endobronchial tuberculosis:
 BAL is usually helpful
▪ AFB smear
▪ AFB culture
▪ GeneXpert MTB/RIF
 Endobronchial sarcoidosis
nonspecific
bronchitis
edema / hyperemia
actively caseating
ulcerative tumourous
granular
fibrostenosis
 Mucosal granularity
 Cobble stone
appearance
 Always perform EBB
form nodules if seen
 TBLB has good yield in
sarcoidosis because
pathology is
peribronchovascular
 TBLB can be combined
with EBB
 Yield is better if both
are combined
 Central necrosis
 Aspiration of pus
 Heterogeneous
echogenecity
 Homogenous or
heterogenous
 Heterogenous pattern:
 Echogenic pattern of lymph
node is not uniform
 Multiple small low echoic
areas
Homogenous
Heterogenous
 Low echoic area within the
lymph node with absence
of blood flow on Doppler
 Commonly seen in
Tuberculosis
Necrosis
No necrosis
Dhooria S, et al. JThor Cardiovasc Surg. 2014
If any of these is positive:Tuberculosis was more
likely
1. Xpert MTB/RIF
2. Tuberculin test
3. Coagulation necrosis sign
4. Heterogenous echotexture of lymphnode on
EBUS
If positive in any specimen: Sputum, BAL
Aspirated pus
 AFB smear
 Culture
 GeneXpert MTB/RIF
 Pus aspirated from lymph node, or any other
site
Sarcoidosis
 More than 2 times ULN
 Raised urinary calcium > 250 mg/24 hr
 Hypercalcemia
 Rarely seen inTuberculosis
SARCOIDOSIS TUBERCULOSIS: AFB +
NECROSIS +
 Caseating necrosis
 Ill formed granuloma
 Intense inflammatory reaction
 AFB +
•Noncaseating
•Compact granulomas
•Sparse lymphocytic cuffing around
granuloma (‘naked’)
•With inclusion bodies at times
 Sarcoidosis may fail to improve with ATT,
however in some spontaneous resolution
may occur
 Tuberculosis may worsen with steroids
Sarcoidosis Tuberculosis
Presentation Walk-in Brought-in
Behaves like Autoimmune disease Infectious disease
Granuloma Non caseating (No central
necrosis
Caseating (Central
necrosis)
Hemoptysis, expectoration Uncommon Common
Lacrimal, parotid and myocardial
involvement
Common Uncommon
Pleural, peritoneal, meningeal and
adrenal involvement
Uncommon Common
Tuberculin test Nearly always negative Nearly always positive
ACE levels > 2 ULN Common Less common
Increased S. Ca and 24 urinary Ca >
250 mg/24 hr
Common Not seen
SARCOIDOSIS: SYMMETRICAL
WITHOUT CENTRAL NECROSIS
TUBERCULOSIS:ASYMMETRICAL
WITH CENTRAL NECROSIS
SARCOIDOSIS: PERILYMPHATIC
NODULES
TUBERCULOSIS:
CENTRILOBULAR NODULES
SARCOIDOSIS: COBBLESTONE TUBERCULOSIS: ULCERATIVE
SARCOIDOSIS
 TBNA/EBUS
 EBB if endobronchial
granularity is present
 TBLB if parenchymal
involvement in HRCT
 Biopsy of involved area ?
Labial biopsy
TUBERCULOSIS
 TBNA/EBUS
 Aspirate pus
 BAL
 AFB smear and culture
 GeneXpert MTB/RIF
SARCOIDOSIS
 No AFB
 No necrosis
TUBERCULOSIS: AFB +
NECROSIS +
Sarcoidosis Tuberculosis
ATT No response Good response unless
MDR
Steroids Dramatic
clinicoradiologic
response
No response
 Thank you !

More Related Content

What's hot

Cns tuberculoma
Cns tuberculomaCns tuberculoma
Cns tuberculoma
macshrestha
 
SARCOIDOSIS
SARCOIDOSISSARCOIDOSIS
Malignant pleural effusions
Malignant pleural effusionsMalignant pleural effusions
Malignant pleural effusions
Kamal Bharathi
 
Superior vena cava syndrome
Superior vena cava syndromeSuperior vena cava syndrome
Superior vena cava syndrome
Sreekanth Nallam
 
Radiology of Tuberculosis
Radiology of TuberculosisRadiology of Tuberculosis
Radiology of Tuberculosis
Mohit Goyal
 
approach to interstitial lung disease
approach to interstitial lung disease approach to interstitial lung disease
approach to interstitial lung disease
ikramdr01
 
Presentation1, radiological imaging of chest wall tumour.
Presentation1, radiological imaging of chest wall tumour.Presentation1, radiological imaging of chest wall tumour.
Presentation1, radiological imaging of chest wall tumour.
Abdellah Nazeer
 
Interstitial lung diseases radiology
Interstitial lung diseases radiologyInterstitial lung diseases radiology
Interstitial lung diseases radiology
Shrikant Nagare
 
Imaging of pulmonary infections
Imaging of pulmonary infectionsImaging of pulmonary infections
Imaging of pulmonary infections
Sahroz Khan
 
Mediastinal mass
Mediastinal massMediastinal mass
Mediastinal mass
Vikram Patil
 
Radiographic manifestations of pulmonary tuberculosis
Radiographic manifestations of pulmonary tuberculosisRadiographic manifestations of pulmonary tuberculosis
Radiographic manifestations of pulmonary tuberculosis
Dev Lakhera
 
Superior vena cava syndrome
Superior vena cava syndromeSuperior vena cava syndrome
Superior vena cava syndrome
rod prasad
 
Radiation pneumonitis
Radiation pneumonitisRadiation pneumonitis
Radiation pneumonitis
Ashraf ElAdawy
 
Cavitatory lesions of the lung
Cavitatory lesions of the lungCavitatory lesions of the lung
Cavitatory lesions of the lung
reddyvjm
 
CNS infections
CNS infectionsCNS infections
CNS infections
Sahil Chaudhry
 
Mediastinal tumors
Mediastinal tumorsMediastinal tumors
Mediastinal tumors
Isha Jaiswal
 
IMAGING IN ABDOMINAL TUBERCULOSIS
IMAGING IN ABDOMINAL TUBERCULOSISIMAGING IN ABDOMINAL TUBERCULOSIS
IMAGING IN ABDOMINAL TUBERCULOSIS
Navni Garg
 

What's hot (20)

Cns tuberculoma
Cns tuberculomaCns tuberculoma
Cns tuberculoma
 
SARCOIDOSIS
SARCOIDOSISSARCOIDOSIS
SARCOIDOSIS
 
A Case of Osler-Rendu-Weber syndrome
A Case of Osler-Rendu-Weber syndromeA Case of Osler-Rendu-Weber syndrome
A Case of Osler-Rendu-Weber syndrome
 
Malignant pleural effusions
Malignant pleural effusionsMalignant pleural effusions
Malignant pleural effusions
 
Superior vena cava syndrome
Superior vena cava syndromeSuperior vena cava syndrome
Superior vena cava syndrome
 
Radiology of Tuberculosis
Radiology of TuberculosisRadiology of Tuberculosis
Radiology of Tuberculosis
 
approach to interstitial lung disease
approach to interstitial lung disease approach to interstitial lung disease
approach to interstitial lung disease
 
Presentation1, radiological imaging of chest wall tumour.
Presentation1, radiological imaging of chest wall tumour.Presentation1, radiological imaging of chest wall tumour.
Presentation1, radiological imaging of chest wall tumour.
 
CXR: Lung Mass - Mediastinal Mass
CXR: Lung Mass - Mediastinal MassCXR: Lung Mass - Mediastinal Mass
CXR: Lung Mass - Mediastinal Mass
 
Interstitial lung diseases radiology
Interstitial lung diseases radiologyInterstitial lung diseases radiology
Interstitial lung diseases radiology
 
Imaging of pulmonary infections
Imaging of pulmonary infectionsImaging of pulmonary infections
Imaging of pulmonary infections
 
Mediastinal mass
Mediastinal massMediastinal mass
Mediastinal mass
 
Radiographic manifestations of pulmonary tuberculosis
Radiographic manifestations of pulmonary tuberculosisRadiographic manifestations of pulmonary tuberculosis
Radiographic manifestations of pulmonary tuberculosis
 
Superior vena cava syndrome
Superior vena cava syndromeSuperior vena cava syndrome
Superior vena cava syndrome
 
Radiation pneumonitis
Radiation pneumonitisRadiation pneumonitis
Radiation pneumonitis
 
Cavitatory lesions of the lung
Cavitatory lesions of the lungCavitatory lesions of the lung
Cavitatory lesions of the lung
 
CNS infections
CNS infectionsCNS infections
CNS infections
 
Mediastinal tumors
Mediastinal tumorsMediastinal tumors
Mediastinal tumors
 
IMAGING IN ABDOMINAL TUBERCULOSIS
IMAGING IN ABDOMINAL TUBERCULOSISIMAGING IN ABDOMINAL TUBERCULOSIS
IMAGING IN ABDOMINAL TUBERCULOSIS
 
Churg strauss syndrome
Churg strauss syndromeChurg strauss syndrome
Churg strauss syndrome
 

Similar to Differentiaitng sarcoidosis from tuberculosis

Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
DR.SHARIF AHSAN
 
SARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptxSARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptx
GouriMohan7
 
Pulmonary Sarcoidosis.pptx
Pulmonary Sarcoidosis.pptxPulmonary Sarcoidosis.pptx
Pulmonary Sarcoidosis.pptx
Umer Farooq
 
Extra pulmonary TB
Extra pulmonary TBExtra pulmonary TB
Extra pulmonary TB
DR.SHARIF AHSAN
 
Ild diagnosis
Ild diagnosis Ild diagnosis
Ild diagnosis
Anusha Jahagirdar
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
Thomas Kurian
 
Roadmap To Diagnosis & Treatment Of Extrapulmonary Tb
Roadmap To Diagnosis & Treatment Of Extrapulmonary TbRoadmap To Diagnosis & Treatment Of Extrapulmonary Tb
Roadmap To Diagnosis & Treatment Of Extrapulmonary Tbliza mariposque
 
Sarcoidosis.ppt
Sarcoidosis.pptSarcoidosis.ppt
Sarcoidosis.ppt
ssuser227d6b
 
Thoracic pathologies in immunocompromised
Thoracic pathologies in immunocompromisedThoracic pathologies in immunocompromised
Thoracic pathologies in immunocompromised
Nihal Ahmed
 
Sarcoidosis imaging
Sarcoidosis imagingSarcoidosis imaging
Sarcoidosis imaging
mohamad hosseinian
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
AakashKaramta1
 
MARY TB PRESENTATIONS.pptx
MARY TB PRESENTATIONS.pptxMARY TB PRESENTATIONS.pptx
MARY TB PRESENTATIONS.pptx
MuniraMohamed6
 
Sarcoidosis sagar gandhi
Sarcoidosis sagar gandhiSarcoidosis sagar gandhi
Sarcoidosis sagar gandhi
Sagar Gandhi
 
Presentation1.pptx, radiological imaging of sarcoidosis.
Presentation1.pptx, radiological imaging of sarcoidosis.Presentation1.pptx, radiological imaging of sarcoidosis.
Presentation1.pptx, radiological imaging of sarcoidosis.
Abdellah Nazeer
 
presentation1-160607012326 (1).pdf
presentation1-160607012326 (1).pdfpresentation1-160607012326 (1).pdf
presentation1-160607012326 (1).pdf
ssuser227d6b
 
CRYPTOCOCCOSIS-APPROACH
CRYPTOCOCCOSIS-APPROACHCRYPTOCOCCOSIS-APPROACH
CRYPTOCOCCOSIS-APPROACH
Dr Pushkar Raj
 
Sarcoidosis agreat mimic
Sarcoidosis agreat mimicSarcoidosis agreat mimic
Sarcoidosis agreat mimichythemhashim
 
CLINICAL CLASSIFICATION OF TUBECULOSIS
CLINICAL  CLASSIFICATION  OF TUBECULOSIS CLINICAL  CLASSIFICATION  OF TUBECULOSIS
CLINICAL CLASSIFICATION OF TUBECULOSIS
Manish Singh
 
Interstitial lung disease
Interstitial lung diseaseInterstitial lung disease
Interstitial lung disease
Dr. Akash Bharti
 

Similar to Differentiaitng sarcoidosis from tuberculosis (20)

Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
SARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptxSARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptx
 
Pulmonary Sarcoidosis.pptx
Pulmonary Sarcoidosis.pptxPulmonary Sarcoidosis.pptx
Pulmonary Sarcoidosis.pptx
 
Extra pulmonary TB
Extra pulmonary TBExtra pulmonary TB
Extra pulmonary TB
 
Ild diagnosis
Ild diagnosis Ild diagnosis
Ild diagnosis
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Roadmap To Diagnosis & Treatment Of Extrapulmonary Tb
Roadmap To Diagnosis & Treatment Of Extrapulmonary TbRoadmap To Diagnosis & Treatment Of Extrapulmonary Tb
Roadmap To Diagnosis & Treatment Of Extrapulmonary Tb
 
Sarcoidosis.ppt
Sarcoidosis.pptSarcoidosis.ppt
Sarcoidosis.ppt
 
Thoracic pathologies in immunocompromised
Thoracic pathologies in immunocompromisedThoracic pathologies in immunocompromised
Thoracic pathologies in immunocompromised
 
Sarcoidosis imaging
Sarcoidosis imagingSarcoidosis imaging
Sarcoidosis imaging
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
MARY TB PRESENTATIONS.pptx
MARY TB PRESENTATIONS.pptxMARY TB PRESENTATIONS.pptx
MARY TB PRESENTATIONS.pptx
 
Sarcoidosis sagar gandhi
Sarcoidosis sagar gandhiSarcoidosis sagar gandhi
Sarcoidosis sagar gandhi
 
Presentation1.pptx, radiological imaging of sarcoidosis.
Presentation1.pptx, radiological imaging of sarcoidosis.Presentation1.pptx, radiological imaging of sarcoidosis.
Presentation1.pptx, radiological imaging of sarcoidosis.
 
presentation1-160607012326 (1).pdf
presentation1-160607012326 (1).pdfpresentation1-160607012326 (1).pdf
presentation1-160607012326 (1).pdf
 
CRYPTOCOCCOSIS-APPROACH
CRYPTOCOCCOSIS-APPROACHCRYPTOCOCCOSIS-APPROACH
CRYPTOCOCCOSIS-APPROACH
 
Sarcoidosis agreat mimic
Sarcoidosis agreat mimicSarcoidosis agreat mimic
Sarcoidosis agreat mimic
 
CLINICAL CLASSIFICATION OF TUBECULOSIS
CLINICAL  CLASSIFICATION  OF TUBECULOSIS CLINICAL  CLASSIFICATION  OF TUBECULOSIS
CLINICAL CLASSIFICATION OF TUBECULOSIS
 
Interstitial lung disease
Interstitial lung diseaseInterstitial lung disease
Interstitial lung disease
 

Recently uploaded

Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
Wasswaderrick3
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Studia Poinsotiana
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
yusufzako14
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
zeex60
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
sanjana502982
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
kejapriya1
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
yqqaatn0
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 

Recently uploaded (20)

Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
 
bordetella pertussis.................................ppt
bordetella pertussis.................................pptbordetella pertussis.................................ppt
bordetella pertussis.................................ppt
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 

Differentiaitng sarcoidosis from tuberculosis

  • 1. Dr. Zia Hashim M.D. (Internal Medicine), D.M. (Pulmonary & CriticalCare), FCCP Associate Professor Department of Pulmonary Medicine Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow
  • 2.  Tuberculosis and sarcoidosis are both granulomatous diseases which affect multiple systems  Tubercular sarcoid:When both of them coexist in the same patient
  • 3.  TB bacilli are inhaled  Engulfed by Alveolar Macrophages but cannot digest  Macrophages lose motility accumulate at the site of injury. More cells are recruited (T cells)  Small area of fibrous cuffing occurs and infection is contained  Disease: If there is change in immunity: granuloma caseates and rupture  Airway  Blood stream
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.  Poorly degraded antigen  Infectious antigens  ? Mycobacterium tuberculosis: strong contender  Non infectious  Pollens  Insecticides
  • 11.  25% of sarcoidosis tissues have evidence of mycobacterial DNA that is 15-fold greater than in nonsarcoidosis control tissues  Copies of mycobacteria DNA in tissue from sarcoidosis patients are  1000-fold less than in the tissues of patients infected with Mycobacterium tuberculosis
  • 12. CONSTITUTIONAL SYMPTOMS  Fever  Malaise  Anorexia  Weight loss  Fatigue RESPIRATORY SYMPTOMS  Cough  Dyspnea  Chest pain
  • 14. TUBERCULOSIS  Asymptomatic: Unlikely  Expectoration  Hemoptysis  Patient is usually sick  If constitutional symptoms are more tuberculosis is more likely SARCOIDOSIS  May remain asymptomatic  Fatigue is characteristic
  • 15. TUBERCULOSIS  Any age  Any sex  Low immunity  Low socioeconomic status SARCOIDOSIS  20-40 years  F: M 2:1
  • 16.  Lofgren’s syndrome  Heerfordt’s syndrome  Lupus pernio  Sjogren like syndrome  Facial nerve palsy: unilateral or bilateral
  • 17.
  • 18.  Fever  Parotid gland enlargement  Uveitis  Xerostomia  Facial nerve palsy: unilateral or bilateral
  • 19.  Characterized by destructive lesions Involvement of  Nose  Alae nasi  Cheek  Nasolabial folds
  • 20.  Granulomatous uveitis (Most common ocular manifestation)  Conjunctival granuloma  Episcleritis  Lacrimal gland involvement (Dry eyes)
  • 21.  Cervical lymphadenopathy  Pleural and pericardial effusion  Ascites  Ileocaecal tuberculosis: Intestinal obstruction  Tubercular meningitis
  • 22.  Tuberculosis: Present  Sarcoidosis: Absent
  • 23.  Lacrimal and parotid: Sarcoidosis  Adrenal gland:Tuberculosis  Myocardial involvement, Heart block: Sarcoidosis
  • 24. POSTTB OBSTRUCTIVE DS CHRONIC END STAGE SARCOIDOSIS
  • 25.  If positive diagnosis of tuberculosis likely but sarcoidosis is very unlikely  But if negative compatible clinical picture is required to exclude tuberculosis with confidence
  • 26. CECT is required for characterization  Sarcoidosis: Symmetrical  Tuberculosis: Asymmetrical
  • 27.  Symmetric hilar and mediastinal lymphadenopathy; without or with characterstic pulmonary changes  Uniform enhancement  Discrete  No central necrosis
  • 28.
  • 29.
  • 30.  Low attenuation or typical rim enhancement with central necrosis  Associated lung changes/ pleural effusion  Often asymmetrical  Heterogeneous
  • 31.
  • 35.
  • 36.
  • 37.
  • 38.  Random:  Touch pleura  Not related to any structure  Centrilobular: Away from pleura in the centre of lobule  Perilymphatic:  Touch pleura  Along vessels, bronchi
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.  Endobronchial tuberculosis:  BAL is usually helpful ▪ AFB smear ▪ AFB culture ▪ GeneXpert MTB/RIF  Endobronchial sarcoidosis
  • 46. nonspecific bronchitis edema / hyperemia actively caseating ulcerative tumourous granular fibrostenosis
  • 47.  Mucosal granularity  Cobble stone appearance  Always perform EBB form nodules if seen
  • 48.  TBLB has good yield in sarcoidosis because pathology is peribronchovascular  TBLB can be combined with EBB  Yield is better if both are combined
  • 49.  Central necrosis  Aspiration of pus  Heterogeneous echogenecity
  • 50.  Homogenous or heterogenous  Heterogenous pattern:  Echogenic pattern of lymph node is not uniform  Multiple small low echoic areas Homogenous Heterogenous
  • 51.  Low echoic area within the lymph node with absence of blood flow on Doppler  Commonly seen in Tuberculosis Necrosis No necrosis
  • 52. Dhooria S, et al. JThor Cardiovasc Surg. 2014
  • 53.
  • 54. If any of these is positive:Tuberculosis was more likely 1. Xpert MTB/RIF 2. Tuberculin test 3. Coagulation necrosis sign 4. Heterogenous echotexture of lymphnode on EBUS
  • 55. If positive in any specimen: Sputum, BAL Aspirated pus  AFB smear  Culture  GeneXpert MTB/RIF  Pus aspirated from lymph node, or any other site
  • 57.  Raised urinary calcium > 250 mg/24 hr  Hypercalcemia  Rarely seen inTuberculosis
  • 58. SARCOIDOSIS TUBERCULOSIS: AFB + NECROSIS +  Caseating necrosis  Ill formed granuloma  Intense inflammatory reaction  AFB + •Noncaseating •Compact granulomas •Sparse lymphocytic cuffing around granuloma (‘naked’) •With inclusion bodies at times
  • 59.  Sarcoidosis may fail to improve with ATT, however in some spontaneous resolution may occur  Tuberculosis may worsen with steroids
  • 60. Sarcoidosis Tuberculosis Presentation Walk-in Brought-in Behaves like Autoimmune disease Infectious disease Granuloma Non caseating (No central necrosis Caseating (Central necrosis) Hemoptysis, expectoration Uncommon Common Lacrimal, parotid and myocardial involvement Common Uncommon Pleural, peritoneal, meningeal and adrenal involvement Uncommon Common Tuberculin test Nearly always negative Nearly always positive ACE levels > 2 ULN Common Less common Increased S. Ca and 24 urinary Ca > 250 mg/24 hr Common Not seen
  • 61. SARCOIDOSIS: SYMMETRICAL WITHOUT CENTRAL NECROSIS TUBERCULOSIS:ASYMMETRICAL WITH CENTRAL NECROSIS
  • 64. SARCOIDOSIS  TBNA/EBUS  EBB if endobronchial granularity is present  TBLB if parenchymal involvement in HRCT  Biopsy of involved area ? Labial biopsy TUBERCULOSIS  TBNA/EBUS  Aspirate pus  BAL  AFB smear and culture  GeneXpert MTB/RIF
  • 65. SARCOIDOSIS  No AFB  No necrosis TUBERCULOSIS: AFB + NECROSIS +
  • 66. Sarcoidosis Tuberculosis ATT No response Good response unless MDR Steroids Dramatic clinicoradiologic response No response